Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Jan 25, 2025. (Total: 235671Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 9 (of 9 Records)

Query Trace: Disease and NQO2[original query]
An association between idiopathic Parkinson's disease and polymorphisms of phase II detoxification enzymes: glutathione S-transferase M1 and quinone oxidoreductase 1 and 2.
Biochemical and biophysical research communications 2001 Nov 288 (4): 887-92.
Harada S, Fujii C, Hayashi A, Ohkoshi
No associations between Parkinson's disease and polymorphisms of the quinone oxidoreductase (NQO1, NQO2) genes.
Neuroscience letters 2005 Mar 375 (3): 178-80.
Okada Starlyn, Farin Federico M, Stapleton Patricia, Viernes Hanna, Quigley Sean D, Powers Karen M, Smith-Weller Terri, Franklin Gary M, Longstreth W T, Swanson Phillip D, Checkoway Harv
Association of NRH:quinone oxidoreductase 2 gene promoter polymorphism with higher gene expression and increased susceptibility to Parkinson's disease.
The journals of gerontology. Series A, Biological sciences and medical sciences 2008 Feb 63 (2): 127-34.
Wang Wei, Le Wei-Dong, Pan Tianhong, Stringer Janet L, Jaiswal Anil
Nitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a Southwest Oncology Group clinical trial.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Aug 15 (16): 5258-66.
Choi Ji-Yeob, Barlow William E, Albain Kathy S, Hong Chi-Chen, Blanco Javier G, Livingston Robert B, Davis Warren, Rae James M, Yeh I-Tien, Hutchins Laura F, Ravdin Peter M, Martino Silvana, Lyss Alan P, Osborne C Kent, Abeloff Martin D, Hayes Daniel F, Ambrosone Christine
Two minor NQO1 and NQO2 alleles predict poor response of breast cancer patients to adjuvant doxorubicin and cyclophosphamide therapy.
Pharmacogenetics and genomics 2011 Dec 21 (12): 808-19.
Jamieson David, Cresti Nicola, Bray Johanne, Sludden Julieann, Griffin Melanie J, Hawsawi Nahed M, Famie Eve, Mould Emily V A, Verrill Mark W, May Felicity E B, Boddy Alan
Association of superoxide dismutases and NAD(P)H quinone oxidoreductases with prognosis of patients with breast carcinomas.
International journal of cancer. Journal international du cancer 2012 Jan 130 (2): 338-48.
Hubackova Miluse, Vaclavikova Radka, Ehrlichova Marie, Mrhalova Marcela, Kodet Roman, Kubackova Katerina, Vrána David, Gut Ivan, Soucek Pav
Genetic variants in oxidative stress-related genes predict chemoresistance in primary breast cancer: a prospective observational study and validation.
Cancer research 2012 Jan 72 (2): 408-19.
Yu Ke-Da, Huang A-Ji, Fan Lei, Li Wen-Feng, Shao Zhi-Mi
Steroidogenic germline polymorphism predictors of prostate cancer progression in the estradiol pathway.
Clinical cancer research : an official journal of the American Association for Cancer Research 2014 Jun 20 (11): 2971-83.
Lévesque Eric, Laverdière Isabelle, Audet-Walsh Etienne, Caron Patrick, Rouleau Mélanie, Fradet Yves, Lacombe Louis, Guillemette Chant
Association Between a Tri-allelic Polymorphism in the Estrogen Metabolism Oxidoreductase NRH:Quinone Oxidoreductase 2 Gene and Risk of Breast Cancer by Molecular Subtype.
Frontiers in genetics 2021 12 658285.
Zhou Jiao-Qun, Zhu Si-Yuan, He Ye, Yu Ke-
TOP